» Articles » PMID: 30120231

Multiple Domains of Bacterial and Human Lon Proteases Define Substrate Selectivity

Overview
Date 2018 Aug 19
PMID 30120231
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The Lon protease selectively degrades abnormal proteins or certain normal proteins in response to environmental and cellular conditions in many prokaryotic and eukaryotic organisms. However, the mechanism(s) behind the substrate selection of normal proteins remains largely unknown. In this study, we identified 10 new substrates of F. tularensis Lon from a total of 21 candidate substrates identified in our previous work, the largest number of novel Lon substrates from a single study. Cross-species degradation of these and other known Lon substrates revealed that human Lon is unable to degrade many bacterial Lon substrates, suggestive of a "organism-adapted" substrate selection mechanism for the natural Lon variants. However, individually replacing the N, A, and P domains of human Lon with the counterparts of bacterial Lon did not enable the human protease to degrade the same bacterial Lon substrates. This result showed that the "organism-adapted" substrate selection depends on multiple domains of the Lon proteases. Further in vitro proteolysis and mass spectrometry analysis revealed a similar substrate cleavage pattern between the bacterial and human Lon variants, which was exemplified by predominant representation of leucine, alanine, and other hydrophobic amino acids at the P(-1) site within the substrates. These observations suggest that the Lon proteases select their substrates at least in part by fine structural matching with the proteins in the same organisms.

Citing Articles

Multitarget mechanism of MYC inhibition by the bacterial lon protease in disease.

Ambite I, Wan M, Tran H, Nazari A, Chaudhuri A, Krintel C Sci Rep. 2025; 15(1):6778.

PMID: 40000737 PMC: 11861601. DOI: 10.1038/s41598-025-88093-2.


Structure, Substrate Specificity and Role of Lon Protease in Bacterial Pathogenesis and Survival.

Kirthika P, Lloren K, Jawalagatti V, Lee J Int J Mol Sci. 2023; 24(4).

PMID: 36834832 PMC: 9961632. DOI: 10.3390/ijms24043422.


New Insights into the Mechanism of Antibacterial Action of Synthetic Peptide -CBP-PepI against .

Branco L, Souza P, Neto N, Aguiar T, Silva A, Carneiro R Antibiotics (Basel). 2022; 11(12).

PMID: 36551410 PMC: 9774128. DOI: 10.3390/antibiotics11121753.


Rare and de novo variants in 827 congenital diaphragmatic hernia probands implicate LONP1 as candidate risk gene.

Qiao L, Xu L, Yu L, Wynn J, Hernan R, Zhou X Am J Hum Genet. 2021; 108(10):1964-1980.

PMID: 34547244 PMC: 8546037. DOI: 10.1016/j.ajhg.2021.08.011.


Endogenous and Borrowed Proteolytic Activity in the .

Coleman J, Benach J, Karzai A Microbiol Mol Biol Rev. 2021; 85(2).

PMID: 33980587 PMC: 8139524. DOI: 10.1128/MMBR.00217-20.


References
1.
Finley D . Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem. 2009; 78:477-513. PMC: 3431160. DOI: 10.1146/annurev.biochem.78.081507.101607. View

2.
Feng J, Michalik S, Varming A, Andersen J, Albrecht D, Jelsbak L . Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus. J Proteome Res. 2012; 12(2):547-58. DOI: 10.1021/pr300394r. View

3.
Rasulova F, Dergousova N, Starkova N, Melnikov E, Rumsh L, GINODMAN L . The isolated proteolytic domain of Escherichia coli ATP-dependent protease Lon exhibits the peptidase activity. FEBS Lett. 1998; 432(3):179-81. DOI: 10.1016/s0014-5793(98)00859-x. View

4.
Puri N, Karzai A . HspQ Functions as a Unique Specificity-Enhancing Factor for the AAA+ Lon Protease. Mol Cell. 2017; 66(5):672-683.e4. PMC: 8054221. DOI: 10.1016/j.molcel.2017.05.016. View

5.
CHAMBERLAIN R . EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM. Appl Microbiol. 1965; 13:232-5. PMC: 1058227. DOI: 10.1128/am.13.2.232-235.1965. View